Weyinshet Gossa, MD, MPH and Michael D. Fetters, MD, MPH, MA
Cervical cancer has become rare in high-income countries but is a leading cause of mortality among women in low- and middle-income countries. This inequity is an epidemiological tragedy.
AMA J Ethics. 2020;22(2):E126-134. doi:
10.1001/amajethics.2020.126.
Martin Bricknell, PhD, David Whetham, PhD, Richard Sullivan, PhD, and Peter Mahoney, PhD
International humanitarian law obliges clinicians to coordinate with local civilian, military, and nongovernment organizations, and implementation isn't easy.
AMA J Ethics. 2022;24(6):E472-477. doi:
10.1001/amajethics.2022.472.
This article examines how the AMA Code of Medical Ethics addresses different kinds of waste generated by health care delivery streams in an era of climate change.
AMA J Ethics. 2022;24(10):E967-970. doi:
10.1001/amajethics.2022.967.
Lisa Patel, MD, MESc and Katie E. Lichter, MD, MPH
Health care generates a lot of waste that enters landfills, oceans, and incinerators and adversely affects communities close to waste processing and disposal areas.
AMA J Ethics. 2022;24(10):E980-985. doi:
10.1001/amajethics.2022.980.
Mismanagement of hospital waste can release harmful, deleterious contaminants into soil, water, and air and can have far-reaching environmental and public relations consequences.
AMA J Ethics. 2022;24(10):E1013-1021. doi:
10.1001/amajethics.2022.1013.
Clara C. Hildebrandt, MD and Jonathan M. Marron, MD, MPH
Gene editing with CRISPR/Cas9 raises concerns about equitable access to therapies that could limit research participation by minority group members. These concerns can be addressed through public education, transparency, and stakeholder partnerships.
AMA J Ethics. 2018;20(9):E826-833. doi:
10.1001/amajethics.2018.826.